Biogen Idec Inc. (BIIB)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 130.84
   
  • Change Today:
    $-0.70
  • 52 Week High: $137.04
  • 52 Week Low: $85.03
  • Currency: US Dollars
  • Shares Issued: 239.56m
  • Volume: 1,272,176
  • Market Cap: $31,344m
  • RiskGrade: 91
  • Beta: 0.78

BIIB Overview

In November 2003, Biogen and IDEC Pharmaceuticals finalised their $6bn merger, creating Biogen Idec, the third-largest biotechnology company in the world. The company is now a global leader in the development, manufacturing, and commercialisation of novel therapies. Its major products include treatments for relapsing multiple sclerosis, certain B-cell non-Hodgkin's lymphomas and adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

1 Day Chart (30-05-2012)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 34.2%
ROCE 36.1%
Latest F'cast
P/E 25.7
PEG 0.9
Pr/Revenue 6.2
Pr/Book 4.9
Latest F'cast
Revenue 7.0%
PBT 39.1%
EPS 27.9%
DPS n/a

BIIB Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 3,171.62 852.17 202.00¢ 28.2 0.1 +216% n/a 0.0%
31-Dec-08 4,097.51 1,155.88 267.00¢ 17.8 0.6 +32% n/a 0.0%
31-Dec-09 4,377.35 1,332.68 337.00¢ 15.9 0.6 +26% n/a 0.0%
31-Dec-10 4,716.42 1,229.91 398.00¢ 16.8 0.9 +18% n/a 0.0%
31-Dec-11 5,048.63 1,711.21 509.00¢ 21.6 0.8 +28% n/a 0.0%

BIIB Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 5,374.52 1,913.47 620.14¢ 21.1 1.0 +22% n/a 0.0%
31-Dec-13 5,893.92 2,235.50 721.25¢ 18.1 1.1 +16% n/a 0.0%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

BIIB ShareCast News

US broker round-up 23-Apr-2012 ShareCast
US broker round-up 04-Apr-2012 ShareCast
US broker round-up 21-Dec-2011 ShareCast

BIIB Top Newspaper Links

Elan says federal judge ruled it broke terms of ... 04-Sep-2009 Chicago Tribune
Johnson & Johnson Buys Access to an Alzheimer’s ... 03-Jul-2009 New York Times
Icahn Places Two Allies on the Biogen Idec Board 04-Jun-2009 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

BIIB Market Data

Currency US Dollars
Share Price $ 130.84
Change Today $ -0.70
% Change -0.53 %
52 Week High $137.04
52 Week Low $85.03
Volume 1,272,176
Shares Issued 239.56m
Market Cap $31,344m
Beta 0.78
RiskGrade 91

What The Brokers Say

Strong Buy 15
Buy 2
Neutral 10
Sell 0
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 30-May-2012

Time Volume / Share Price
16:00 104 @ $130.84
16:00 92,802 @ $130.84
15:59 200 @ $130.80
15:59 100 @ $130.81
15:59 200 @ $130.81

Top of Page